Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2019-04-19 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company about a change in accounting policies related to the adoption of new financial instrument accounting standards effective from January 1, 2019. It includes details about the reasons for the change, the previous and new accounting policies, and the impact on the company. The document references a board meeting resolution approving the change but does not contain full financial statements or comprehensive financial data. The length is short (1991 characters) and it is primarily an announcement of a policy change rather than a full financial report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about accounting policy changes without the full report itself.
2019-04-19 Chinese
关于公司实际控制人股份质押延期购回的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the extension of the repurchase period for pledged shares held by the company's actual controller. It details the number of shares pledged, the pledge start and original expiry dates, the new repurchase date, and the proportion of shares pledged. There is no financial report, earnings data, or management discussion. The document is short (830 characters) and serves as a regulatory disclosure about share pledge status, which fits the category of Regulatory Filings (RNS) as it does not fit other more specific categories like share issue or director dealings.
2019-04-11 Chinese
2019年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is a quarterly earnings forecast for the first quarter of 2019, providing estimated net profit growth and reasons for performance changes. It explicitly states that the forecast has not been audited and that detailed financial data will be disclosed in the actual quarterly report later. The document is short (847 characters) and serves as an initial announcement of quarterly financial results, which aligns with the definition of an Earnings Release (ER). Q1 2019
2019-04-09 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, prices, compliance with regulatory rules, and timing of the repurchase activities. It references relevant regulations and previous approvals but does not contain financial statements or earnings data. The document length is short (1347 characters) and is clearly an update on the share buyback activity rather than a full financial report or earnings release. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers announcements of share repurchase activities.
2019-04-01 Chinese
2019年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the 2019 first extraordinary general meeting of shareholders of Dirui Medical Technology Co., Ltd. It details the meeting date, voting procedures, attendance, and voting results on a proposal to amend the company's articles of association. It also includes a legal opinion confirming the legality of the meeting and voting process. The document is an official announcement of the voting results from a shareholders' meeting, not the meeting materials or the full report itself. The document length is short (1784 characters), and it primarily reports the voting outcomes and legal validation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-03-25 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate. It includes details about the patent number, invention name, inventors, and patent rights. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, or voting results. The document is an official company announcement about intellectual property, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a patent grant, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-03-25 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.